<menu id="wymuy"><strong id="wymuy"></strong></menu>
  • <menu id="wymuy"><strong id="wymuy"></strong></menu> <menu id="wymuy"></menu>
  • <menu id="wymuy"></menu>
  • <input id="wymuy"></input>
  • Assay for Sickle Cell Anemia Is Repurposed to Diagnose COVID-19
    Assay for Sickle Cell Anemia Is Repurposed to Diagnose COVID-19
    A CRISPR-based, paper-strip test developed by Indian researchers performs as well as real-time PCR in identifying the presence of SARS-CoV-2 and returns results within an hour.
    Assay for Sickle Cell Anemia Is Repurposed to Diagnose COVID-19
    Assay for Sickle Cell Anemia Is Repurposed to Diagnose COVID-19

    A CRISPR-based, paper-strip test developed by Indian researchers performs as well as real-time PCR in identifying the presence of SARS-CoV-2 and returns results within an hour.

    A CRISPR-based, paper-strip test developed by Indian researchers performs as well as real-time PCR in identifying the presence of SARS-CoV-2 and returns results within an hour.

    coronavirus
    Breastmilk Harbors Antibodies to SARS-CoV-2
    Breastmilk Harbors Antibodies to SARS-CoV-2
    Ashley Yeager | Nov 17, 2020
    An abundance of immunoglobulin antibodies, and a paucity of viral RNA, in breastmilk offer evidence that women can safely continue breastfeeding during the pandemic.
    Moderna&rsquo;s COVID-19 Vaccine 94 Percent Effective: Initial Data
    Moderna’s COVID-19 Vaccine 94 Percent Effective: Initial Data
    Max Kozlov | Nov 16, 2020
    The results mark the second experimental COVID-19 vaccine to show high efficacy, but the study is not complete and the data have not been peer reviewed.
    Q&amp;A: Minks Can Transmit SARS-CoV-2 to Humans, Study Shows
    Q&A: Minks Can Transmit SARS-CoV-2 to Humans, Study Shows
    Max Kozlov | Nov 13, 2020
    Whole genome sequencing of the virus infecting the farm animals showed that it spread from the workers to the mink and back, indicating that an animal could serve as a viral reservoir.
    SARS-CoV-2 Exits Cells Via Lysosomes
    SARS-CoV-2 Exits Cells Via Lysosomes
    Abby Olena | Nov 13, 2020
    A study finds that β-coronaviruses don’t use the normal secretory pathway, a possible explanation for some aspects of COVID-19 pathology.
    Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
    Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
    Anthony King | Nov 11, 2020
    Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
    Beyond Acute Respiration: SARS-CoV-2&#39;s Effects on Long-Term Physiology
    Beyond Acute Respiration: SARS-CoV-2's Effects on Long-Term Physiology
    The Scientist Creative Services Team | Nov 11, 2020
    John Connolly and Masataka Nishiga discuss the effects of SARS-CoV-2 on the neurological and cardiovascular systems.
    Q&amp;A: Pollution Linked to 15 Percent Increase in COVID-19 Deaths
    Q&A: Pollution Linked to 15 Percent Increase in COVID-19 Deaths
    Lisa Winter | Nov 10, 2020
    Jos Lelieveld of the Max Planck Institute for Chemistry explains how fine particulate might contribute to deaths from COVID-19.
    Updated
    Pfizer&rsquo;s COVID-19 Vaccine 90 Percent Effective: Initial Data
    Pfizer’s COVID-19 Vaccine 90 Percent Effective: Initial Data
    Max Kozlov | Nov 9, 2020
    Vaccine experts say the results surpass their expectations, but the study is not complete, and the data have not been peer reviewed.
    Doctors Consider Convalescent T Cell Therapy for COVID-19
    Doctors Consider Convalescent T Cell Therapy for COVID-19
    Abby Olena | Nov 6, 2020
    Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.
    精选二四六天天好彩j